78. Hypopituitarism Clinical trials / Disease details


Clinical trials : 494 Drugs : 385 - (DrugBank : 49) / Drug target genes : 44 - Drug target pathways : 100

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00133354
(ClinicalTrials.gov)
November 200119/8/2005Arimidex Multicenter Trial in Growth Hormone (GH) Deficient BoysDouble-blind Trial Investigating the Safety and Efficacy of the Inhibitor Anastrozole (ARIMIDEX) in Delaying Epiphyseal Fusion and Increasing Height Potential of Adolescent Males With Growth Hormone (GH) DeficiencyHypopituitarismDrug: Arimidex (Anastrozole);Drug: Placebo;Drug: Growth HormoneNemours Children's ClinicAstraZeneca;Genentech, Inc.;EMD SeronoCompleted11 Years18 YearsMale53Phase 2/Phase 3United States